Quartesian, a leading data CRO quickly becoming a clinical data services industry favorite, recently announced a second consecutive year of record contract bookings and revenue. With a revenue increase of 40%, and bookings increasing over 62% versus the previous year, it’s clear that Quartesian’s aim to help life sciences companies advance their scientific goals is being met.
For both companies and customers alike, a pipeline increase of over 80% signifies Quartesian is capable of offering an even broader set of data capture and management capabilities. As they continue to to experience booming demand for their modern brand of high quality, cost-efficient clinical data services, it’s no secret that CROs are noticing.
With the flexibility to add expert SAS and Medidata Rave resources on demand, Quartesian has provided thousands of CDISC SDTM datasets to their customers — all with zero change orders.
“High quality, fast, efficient clinical data at an affordable price should be the norm, not the exception,” said Soumitra Chowdhury, COO of Quartesian. “That’s our mantra, and that’s what we plan to continue delivering to our customers…”